ClinicalTrials.Veeva

Menu

Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy.

Pierre Fabre logo

Pierre Fabre

Status

Completed

Conditions

Open Cracked Heel in Diabetic Patients With Polyneuropathy

Treatments

Device: Tested product : V0111 cream
Device: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT02045199
2013-A01394-41 (Other Identifier)
V00111 CR 0 02

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and the safety of the cream V0111 in the treatment of fissure(s) situated on the heels in diabetic patients with polyneuropathy.

Enrollment

193 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetes mellitus with neuropathy,
  • Cracked open heel with at least one fissure Grade 2,

Exclusion criteria

  • Open wound, skin infection, haemorrhagic crack on feet,
  • Major static disorder ,
  • Ulceration and history of ulceration,
  • Active haemorrhagic crack,
  • Hyperkeratotic disease
  • Diabetic arteriopathy,

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

193 participants in 2 patient groups, including a placebo group

V0111
Experimental group
Treatment:
Device: Tested product : V0111 cream
Placebo
Placebo Comparator group
Treatment:
Device: Placebo

Trial contacts and locations

20

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems